Reduced expression of ACE2 has been observed to be associated with various conditions such as hypertension, diabetes, and cardiovascular conditions, which are also associated with COVID-19 as comorbidities (Magrone et al., 2020). Here, ACE2 is linked to diabetes mellitus.